GOSS short interest
Gossamer Bio Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 1,237,721 |
|---|---|
| Change vs prior report | 289,098 (+30.5%) |
| Change over six months | -96.7% |
| Days to cover | 3.50 (sector: 3.78) |
| Average daily volume | 353,408 |
| Rank in Healthcare | #586 of 922 by days to cover |
GOSS short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 1,237,721 | +30.5% | 3.50 | 353,408 |
| 2026-09-15 | 948,623 | -98.8% | 5.07 | 186,993 |
| 2026-08-31 | 82,633,317 | -4.8% | 2.79 | 29,606,971 |
| 2026-08-14 | 86,786,498 | -8.6% | 7.37 | 11,783,142 |
| 2026-07-31 | 94,986,016 | +29.8% | 1.49 | 63,584,808 |
| 2026-07-15 | 73,178,841 | +36.3% | 3.79 | 19,310,997 |
| 2026-06-30 | 53,695,991 | -4.5% | 3.22 | 16,674,771 |
| 2026-06-15 | 56,212,006 | -10.5% | 3.41 | 16,462,056 |
| 2026-05-29 | 62,815,917 | +53.8% | 2.84 | 22,102,118 |
| 2026-05-15 | 40,838,667 | +2.0% | 11.48 | 3,558,686 |
| 2026-04-30 | 40,018,309 | -0.4% | 7.65 | 5,234,457 |
| 2026-04-15 | 40,196,107 | +7.2% | 4.85 | 8,292,309 |
| 2026-03-31 | 37,500,300 | +2.4% | 2.75 | 13,614,400 |
| 2026-03-13 | 36,622,286 | +5.5% | 2.70 | 13,565,159 |
| 2026-02-27 | 34,715,538 | +11.7% | 1.00 | 44,951,614 |
| 2026-02-13 | 31,092,342 | +16.1% | 5.10 | 6,094,020 |
| 2026-01-30 | 26,779,236 | +6.2% | 5.68 | 4,713,026 |
| 2026-01-15 | 25,222,443 | +4.6% | 5.43 | 4,646,927 |
| 2025-12-31 | 24,114,833 | +18.7% | 4.66 | 5,172,180 |
| 2025-12-15 | 20,310,911 | -13.3% | 5.73 | 3,543,881 |
| 2025-11-28 | 23,438,565 | -4.0% | 8.22 | 2,852,104 |
| 2025-11-14 | 24,422,288 | -2.0% | 9.45 | 2,583,683 |
| 2025-10-31 | 24,918,422 | -6.9% | 8.01 | 3,111,094 |
| 2025-10-15 | 26,759,668 | -2.3% | 8.24 | 3,248,248 |
| 2025-09-30 | 27,397,216 | +14.2% | 6.44 | 4,255,013 |
import finzdata as yf
yf.Ticker("GOSS").short_interest # every report since 2017
yf.Client().short_interest(["GOSS"], start="2018-01-01")Healthcare short interest · GOSS price history · Who owns GOSS · All short interest